5-Years Analysis of Effectivity and Toxicity of Ultra-Hypofractionated Proton Radiotherapy in the Treatment of Low- and Intermediate-Risk Prostate Cancer-A Retrospective Analysis.

Jiri KubešSilvia SlávikováPavel VítekAlexandra HaasBarbora OndrováKateřina DedečkováAndrlik MichalMartin DomanskýKateřina JiránkováVeronika SchlencováAnh HarazimováBarbora TurkováTomáš DoležalSarah Falah Abass Al-HamamiVladimír Vondráček

Published in: Cancers (2023)

Ultra-hypofractionated proton beam radiotherapy is an effective treatment for low- and favorable intermediate-risk prostate cancer, with long-term bDFS rates comparable to other techniques. It is promising for unfavorable intermediate-risk prostate cancer and has acceptable long-term GI and favorable GU toxicity.

Keyphrases

prostate cancer
radiation therapy
radical prostatectomy
early stage
oxidative stress
high resolution
radiation induced
locally advanced
combination therapy